Analysis Topic: Companies AnalysisThe analysis published under this topic are as follows.
Wednesday, August 14, 2013
How to Invest in India's $10 Billion Defense Sector, New Regional Arms Race / Companies / Sector Analysis
Greg Madison writes: Here's how the other emerging Asian power can make money for investors
China's desire to dominate the seas of Asia is being challenged by an emerging regional rival - India.
With this shift in the balance of power in Asia, those who know how to invest in India's military and economic rise stand to profit handsomely from a real "ground floor" opportunity.Read full article... Read full article...
Tuesday, August 13, 2013
Greg Madison writes: President Barack Obama added an unexpected twist to the patent wars when he took the extraordinarily rare step of vetoing the International Trade Commission's own trade sanctions against Apple Inc. (Nasdaq: AAPL) last week.
The trade commission had ruled that Apple violated some of Samsung Electronics Co. Ltd's patents, and the commission was set to ban outright several key Apple products, such as the iPhone 3GS, iPhone 4, and the iPad 2 and 3G models - all sold by AT&T Inc. (NYSE:T), among others.Read full article... Read full article...
Tuesday, August 13, 2013
Greg Madison writes: What a surprise. The big banks are not playing by the rules -- the rule of law, that is.
News last week revealed that Bank of America Corp. (NYSE:BAC) and JPMorgan Chase & Co. (NYSE:JPM) are dirty, dirty, dirty.Read full article... Read full article...
Tuesday, August 13, 2013
By Doug Hornig, Senior Editor
The rise of humans from fearful creatures huddled around cave fires to the dominant species on the planet largely parallels the evolution of weaponry. Different subgroups rose and fell, spreading their culture or declining in influence as they either came up with the new best thing with which to slaughter their neighbors or fell behind in the innovation game.
Club, axe, spear, atlatl, sword, longbow, crossbow, catapult, gun, bomb, artillery, really big bomb—all have had their day.Read full article... Read full article...
Friday, August 09, 2013
Improve The Productivity Of Your Dividend Growth Portfolio With Technology Stocks / Companies / Tech Stocks
Introduction and General Observations of the Information Technology Sector
Dividend growth investors seeking quality dividend growth stocks to fund their retirement portfolios have not historically looked to the Information Technology sector. Traditionally, the Information Technology sector has been associated with higher growth and higher risk. However, in addition to higher growth, many technology companies are also very cyclical in nature. Another common attribute for tech companies is how they have traditionally utilized their capital. In order to finance their high-growth needs, the majority of Information Technology companies have traditionally not paid dividends. Instead, they used their capital to fund future growth. However, another contributing factor to the no dividend policy of Information Technology companies was the nascent nature of this industry.Read full article... Read full article...
Wednesday, August 07, 2013
Diane Alter writes: Facebook (Nasdaq: FB) stock closed over $39 for the first time ever Monday, but the gains were short-lived. In mid-morning trading Tuesday, FB shares slipped more than 2% to $37.94.
Nonetheless, Monday's milestone, which took a long 14 months to achieve, left many investors giddy - and confused.Read full article... Read full article...
Tuesday, August 06, 2013
We’ve recently written a couple articles on ETFs—exchange traded funds—to help investors understand the difference between them and mutual funds and to show how for nearly every mutual fund you can find an nearly identical ETF that charges much less in fees. And each time we come out with a new article we get even more questions from readers.Read full article... Read full article...
Monday, August 05, 2013
Greg Madison writes: If there's one sector that's primed for explosive growth right now, it's biotechnology.
Its position as a new market leader in the tech sector cannot be overstated. Clearly, investing in biotech is an idea few can afford to ignore.Read full article... Read full article...
Saturday, August 03, 2013
The cause of the financial crisis of 2007 -2008, also known as the Great Recession of 2008, is attributed to many different theories. However, one of the most common theories is an easy money regulatory environment that led to an abundance of subprime loans, which in turn inflated real estate prices to bubble levels. Additionally, many blame the Financial sector, predominantly the money center banks, for exploiting the lax lending requirements with reckless and greedy behavior. They did this through the creation of and proliferation of high risk bundled subprime mortgages (CMO’s, etc.) and the creation of other high risk and complex financial products that were being pawned off as safe investments.
Additionally, many attribute the repeal of the Glass-Steagall Act in 1999 as a major contributor to the financial crisis, which effectively removed the separation between investment banks and depository banks in the United States. There was plenty of blame to go around, which included avarice, greed and excesses on Wall Street, and the failure of regulators to include many of the most prominent credit rating agencies.Read full article... Read full article...
Friday, August 02, 2013
The Technology Jobs Conundrum
The past few weeks have seen the tech and business media abuzz about a not-so-little warehouse in Tennessee. That's because this distribution center, opening its doors with a burst of fanfare and even a few visits from nearby politicians, isn't a jumping-off point for Macy's or Target. Instead, the warehouse is the latest in a series of new locations being opened by retail technology giant Amazon.com.
The jobs this new mega-warehouse is purported to create: 5,000.Read full article... Read full article...
Thursday, August 01, 2013
Senior Biotechnology Analyst Jason Napodano of Zacks Investment Research specializes in uncovering small biotech and medtech companies with good prospects for successful drug development. He relishes proven management capable of creative financing to move private equity into the public markets, and he does not shy away from tiny companies outside the U.S. that have extraordinary technology. In this wide-ranging interview with The Life Sciences Report, Napodano presents the elegant growth stories of seven small companies that could return magnificent gains to investors.
The Life Sciences Report: Jason, you follow some companies that are not domiciled in the U.S. Are there special considerations or concerns that investors should be aware of before investing in stocks outside U.S. markets?Read full article... Read full article...
Monday, July 29, 2013
William Patalon writes: I was at work here at the office last Monday night when I heard about the Boeing 737 crash at New York's LaGuardia Airport. A nose wheel on the jetliner had apparently given way after a hard touchdown just after 5:30 p.m. (EDT), leading to a crash that injured about eight of the 150 folks on board
"Uh-oh," I thought to myself. "Here comes another feeding frenzy."
You're an exceptionally sharp group of folks, so you know what I'm getting at here.Read full article... Read full article...
Sunday, July 28, 2013
Investors Look at Health Care Sector Stocks for a Healthier Portfolio / Companies / Healthcare Sector
The Health Care sector is comprised of many diverse companies, as can be seen from the list of subsectors provided below. Historically the Health Care sector has been comprised of a significant number of companies with above-average growth rates of earnings. Consequently, a majority of the companies comprising the Health Care sector could be thought of as growth stocks over dividend growth stocks.
One of the primary reasons for this was that the sector was benefiting from the tailwinds of the powerful demographic forces of an aging population. Additionally, there were many scientific advances that also provided above-average growth to many companies in this sector. As a result, health care stocks were once considered defensive because they were mostly unaffected by economic weakness.Read full article... Read full article...
Sunday, July 28, 2013
The pricey evolutionary tradeoff for walking on two legs is the curse of lower back pain. Jason Kolbert of the Maxim Group understands the power of stem cells as disease-modifying therapies for degenerative disc disease of the spine, a leading-edge, multibillion-dollar indication. Kolbert explores the opportunities that cell therapies offer investors in this interview with The Life Sciences Report, and puts a personal spin on their regenerative promise.
The Life Sciences Report: Jason, I wanted to ask you some questions about degenerative disc disease (DDD) and the use of cell therapy to manage the problem. Some people have said that the spine is a hostile environment. Why is it hostile?Read full article... Read full article...
Friday, July 26, 2013
Garrett Baldwin writes: U.S. and global companies may be sitting atop piles of cash as the stock market hovers near all-time highs, but total capital expenditures likely will fall over the next two years.
Reductions in capital expenditure in heavy spending commodity sectors, such as energy and mining, will drive down inflation-adjusted spending by 2 percent in 2013 and 5 percent in 2014, according to Standard and Poor's.Read full article... Read full article...